Vertex Pharmaceuticals (VRTX) Other Gross PP&E Adjustments (2009 - 2026)

Vertex Pharmaceuticals' Other Gross PP&E Adjustments history runs 18 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments fell 25.89% year-over-year to -$1.7 billion; the TTM figure through Mar 2026 stood at -$1.7 billion (down 25.89% YoY), while the FY2025 annual figure was $989.9 million, up 28.29% from the prior year.
• Other Gross PP&E Adjustments was -$1.7 billion for Q1 2026 at Vertex Pharmaceuticals, down from $989.9 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.9 billion in Q4 2023 to a low of -$1.7 billion in Q1 2026.
• Historically, Other Gross PP&E Adjustments has averaged -$282.4 million across 5 years, with a median of -$329.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Gross PP&E Adjustments slumped 349.63% in 2024, then rose 28.29% in 2025.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.7 billion in 2022, then increased by 12.66% to $1.9 billion in 2023, then plunged by 59.61% to $771.6 million in 2024, then climbed by 28.29% to $989.9 million in 2025, then slumped by 270.23% to -$1.7 billion in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$1.7 billion (Q1 2026), $989.9 million (Q4 2025), and -$1.6 billion (Q3 2025), per Business Quant data.